The Eimen Kaminski Group
William Blair Private Wealth Management
About William Blair
William Blair is a premier global partnership with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 30 offices worldwide.*
-
1935Year William Blair was founded
-
2,100+Employees worldwide
-
156 billion+Client assets
-
90+ YearsIndependent and employee-owned
-
30+Offices worldwide*
-
700+Companies under coverage
As of June 30, 2026
*Includes strategic alliances with Allier Capital, BDA Partners, and Poalim Equity Ltd.
Thought Leadership
Our Latest News
-
Beta Bionics, Inc. and Tandem Diabetes Care, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Beta Bionics, Inc. (BBNX $20.01) and Tandem Diabetes Care, Inc. (TNDM $23.46), medical technology companies that develop, manufacture, and market automated insulin delivery systems for the management of diabetes.
-
Surrozen, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Surrozen, Inc. (SRZN $24.00), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling to address the underlying drivers of disease in sight-threatening ophthalmic conditions.
-
Enliven Therapeutics, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Enliven Therapeutics, Inc. (ELVN $58.82), a late-stage biotech focused on developing ELVN-001, a potent and selective tyrosine kinase inhibitor (TKI), for the treatment of chronic myeloid leukemia (CML).